Real-world analysis of cost, treatment patterns, and outcomes of patients with metastatic cutaneous squamous cell carcinoma in the US

医学 西妥昔单抗 内科学 卡铂 放射治疗 肿瘤科 化疗 顺铂 回顾性队列研究 癌症 结直肠癌
作者
Xue Song,Chieh-I Chen,Gerasimos Konidaris,Nicole M. Zimmerman,Emily Ruiz
出处
期刊:Expert Review of Pharmacoeconomics & Outcomes Research [Taylor & Francis]
卷期号:: 1-10
标识
DOI:10.1080/14737167.2023.2223982
摘要

Objectives To describe real-world characteristics and treatment patterns of patients with metastatic cutaneous squamous cell carcinoma (mCSCC).Methods This retrospective observational study used MarketScan Commercial and Medicare Supplemental claims databases (1/1/2013–7/31/2019). Adult patients with mCSCC who initiated non-immunotherapy systemic treatment (i.e. index event) between 1 January 2014 and 31 December 2018 were assessed for treatment patterns, all-cause and CSCC-related healthcare resource utilization, costs, and mortality .Results Overall, 207 patients were included in the study(mean age 64.8 years, 76.3% male), 59.4% had prior radiotherapy, and 58.9% had prior CSCC-related surgery. During follow-up, 75.8%, 51.7%, and 35.7% of patients received chemotherapy, radiotherapy, and targeted therapy as first-line treatment, respectively. Cisplatin (32.9%) and carboplatin (22.7%) were the most common chemotherapy agents, and cetuximab (32.4%) was the most common targeted therapy during the first-line.Probability of death (95% CI) at month 6, year 1, and year 2 was 24% (16–32%), 50% (40 − 59%), and 67% (56 − 75%), respectively. Average CSCC-related healthcare costs were $5,354 per person per month (PPPM), with outpatient costs being the major cost driver at 96.4% ($5,160 PPPM).Conclusion During 2014–2018, patients with mCSCC were commonly treated with cisplatin and cetuximab; prognosis was generally poor. These results indicate opportunity for new treatments to improve survival outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
科研路上互帮互助,共同进步完成签到 ,获得积分10
1秒前
1秒前
美满的稚晴完成签到 ,获得积分10
1秒前
shanekhost完成签到 ,获得积分10
3秒前
量子星尘发布了新的文献求助10
4秒前
5秒前
6秒前
6秒前
7秒前
完美世界应助Infinit采纳,获得10
9秒前
Teko发布了新的文献求助10
11秒前
Akim应助油个大饼呜呜呜采纳,获得10
11秒前
chris完成签到,获得积分10
11秒前
FXQ123_范发布了新的文献求助10
11秒前
11秒前
12秒前
12秒前
14秒前
14秒前
机灵飞阳发布了新的文献求助10
16秒前
17秒前
17秒前
18秒前
18秒前
斯文败类应助Teko采纳,获得10
18秒前
脑洞疼应助小左采纳,获得10
20秒前
22秒前
嗯嗯发布了新的文献求助10
23秒前
23秒前
浮生发布了新的文献求助10
23秒前
24秒前
Teko完成签到,获得积分10
27秒前
英俊的铭应助程之杭采纳,获得10
27秒前
30秒前
喻义梅发布了新的文献求助10
30秒前
jk发布了新的文献求助10
31秒前
可爱的安萱完成签到,获得积分10
33秒前
orixero应助尼莫采纳,获得10
34秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989263
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253814
捐赠科研通 3270066
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136